131 related articles for article (PubMed ID: 25724199)
1. Single stem cell gene therapy for genetic skin disease.
Larsimont JC; Blanpain C
EMBO Mol Med; 2015 Apr; 7(4):366-7. PubMed ID: 25724199
[TBL] [Abstract][Full Text] [Related]
2. A single epidermal stem cell strategy for safe ex vivo gene therapy.
Droz-Georget Lathion S; Rochat A; Knott G; Recchia A; Martinet D; Benmohammed S; Grasset N; Zaffalon A; Besuchet Schmutz N; Savioz-Dayer E; Beckmann JS; Rougemont J; Mavilio F; Barrandon Y
EMBO Mol Med; 2015 Apr; 7(4):380-93. PubMed ID: 25724200
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
Cutlar L; Greiser U; Wang W
Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073
[TBL] [Abstract][Full Text] [Related]
4. Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model.
Wu W; Lu Z; Li F; Wang W; Qian N; Duan J; Zhang Y; Wang F; Chen T
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1660-1665. PubMed ID: 28137859
[TBL] [Abstract][Full Text] [Related]
5. Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.
Jacków J; Titeux M; Portier S; Charbonnier S; Ganier C; Gaucher S; Hovnanian A
J Invest Dermatol; 2016 Jul; 136(7):1346-1354. PubMed ID: 26994967
[TBL] [Abstract][Full Text] [Related]
6. A non-viral gene therapy for treatment of recessive dystrophic epidermolysis bullosa.
Cutlar L; Zhou D; Hu X; Duarte B; Greiser U; Larcher F; Wang W
Exp Dermatol; 2016 Oct; 25(10):818-20. PubMed ID: 27117059
[No Abstract] [Full Text] [Related]
7. Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa.
Wenzel D; Bayerl J; Nyström A; Bruckner-Tuderman L; Meixner A; Penninger JM
Sci Transl Med; 2014 Nov; 6(264):264ra165. PubMed ID: 25429058
[TBL] [Abstract][Full Text] [Related]
8. An RNA-targeted therapy for dystrophic epidermolysis bullosa.
Peking P; Koller U; Duarte B; Murillas R; Wolf S; Maetzig T; Rothe M; Kocher T; García M; Brachtl G; Schambach A; Larcher F; Reichelt J; Bauer JW; Murauer EM
Nucleic Acids Res; 2017 Sep; 45(17):10259-10269. PubMed ID: 28973459
[TBL] [Abstract][Full Text] [Related]
9. Correction of dog dystrophic epidermolysis bullosa by transplantation of genetically modified epidermal autografts.
Gache Y; Pin D; Gagnoux-Palacios L; Carozzo C; Meneguzzi G
J Invest Dermatol; 2011 Oct; 131(10):2069-78. PubMed ID: 21697889
[TBL] [Abstract][Full Text] [Related]
10. Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa.
Murauer EM; Gache Y; Gratz IK; Klausegger A; Muss W; Gruber C; Meneguzzi G; Hintner H; Bauer JW
J Invest Dermatol; 2011 Jan; 131(1):74-83. PubMed ID: 20720561
[TBL] [Abstract][Full Text] [Related]
11. Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo.
Woodley DT; Keene DR; Atha T; Huang Y; Ram R; Kasahara N; Chen M
Mol Ther; 2004 Aug; 10(2):318-26. PubMed ID: 15294178
[TBL] [Abstract][Full Text] [Related]
12. Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosa.
Vanden Oever M; Twaroski K; Osborn MJ; Wagner JE; Tolar J
Pediatr Res; 2018 Jan; 83(1-2):318-324. PubMed ID: 29593249
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector (GENEGRAFT).
Hum Gene Ther Clin Dev; 2014 Jun; 25(2):65-6. PubMed ID: 24933565
[No Abstract] [Full Text] [Related]
14. siRNA-mediated allele-specific inhibition of mutant type VII collagen in dominant dystrophic epidermolysis bullosa.
Pendaries V; Gasc G; Titeux M; Tonasso L; Mejía JE; Hovnanian A
J Invest Dermatol; 2012 Jun; 132(6):1741-3. PubMed ID: 22336946
[No Abstract] [Full Text] [Related]
15. Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue.
Ortiz-Urda S; Lin Q; Green CL; Keene DR; Marinkovich MP; Khavari PA
J Clin Invest; 2003 Jan; 111(2):251-5. PubMed ID: 12531881
[TBL] [Abstract][Full Text] [Related]
16. A biologic Velcro patch.
Tolar J; Wagner JE
N Engl J Med; 2015 Jan; 372(4):382-4. PubMed ID: 25607432
[No Abstract] [Full Text] [Related]
17. Recessive Dystrophic Epidermolysis Bullosa: Advances in the Laboratory Leading to New Therapies.
Woodley DT; Chen M
J Invest Dermatol; 2015 Jul; 135(7):1705-1707. PubMed ID: 26066885
[No Abstract] [Full Text] [Related]
18. Type VII Collagen Replacement Therapy in Recessive Dystrophic Epidermolysis Bullosa-How Much, How Often?
South AP; Uitto J
J Invest Dermatol; 2016 Jun; 136(6):1079-1081. PubMed ID: 27212645
[TBL] [Abstract][Full Text] [Related]
19. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa.
Goto M; Sawamura D; Ito K; Abe M; Nishie W; Sakai K; Shibaki A; Akiyama M; Shimizu H
J Invest Dermatol; 2006 Apr; 126(4):766-72. PubMed ID: 16439972
[TBL] [Abstract][Full Text] [Related]
20. Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa.
Gache Y; Baldeschi C; Del Rio M; Gagnoux-Palacios L; Larcher F; Lacour JP; Meneguzzi G
Hum Gene Ther; 2004 Oct; 15(10):921-33. PubMed ID: 15585108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]